Cardioprotective Properties of HDL: Structural and Functional Considerations.

作者: Eleni Pappa , Moses S. Elisaf , Christina Kostara , Eleni Bairaktari , Vasilis K. Tsimihodimos

DOI: 10.2174/0929867326666190201142321

关键词:

摘要: BACKGROUND As Mendelian Randomization (MR) studies showed no effect of variants altering HDL-cholesterol (HDL-C) levels concerning Cardiovascular Disease (CVD) and novel therapeutic interventions aiming to raise HDL-C resulted futility, the usefulness is unclear. OBJECTIVE role currently doubtful, it suggested that atheroprotective functions HDLs can be attributed number HDL particles, their characteristics including lipid protein components. Scientific interest has focused on function causes rendering particles dysfunctional, whereas relevance subclasses with CVD remains controversial. METHODS The present review discusses changes in quality as much quantity pathological conditions connection between particle concentration cardiovascular disease mortality. Emphasis given recently available data cholesterol efflux capacity parameters determine functionality, well recent investigations associations RESULTS MR or pharmacological targeting are not favor hypothesis relationship CVD. search biomarkers relate functionality needed. Similarly, size exhibit controversial context further CONCLUSION There room for old concept a silver bullet,as cannot considered robust marker does reflect importance number. Elucidation complex system, finding biomarkers, will allow development any HDL-targeted therapy.

参考文章(144)
Meliana Riwanto, Lucia Rohrer, Arnold von Eckardstein, Ulf Landmesser, Dysfunctional HDL: From Structure-Function-Relationships to Biomarkers Handbook of experimental pharmacology. ,vol. 224, pp. 337- 366 ,(2015) , 10.1007/978-3-319-09665-0_10
Anatol Kontush, M. John Chapman, High-Density Lipoproteins: Structure, Metabolism, Function, and Therapeutics John Wiley & Sons, Inc.. ,(2011) , 10.1002/9781118158678
Oliver F. de Lalla, John W. Gofman, Ultracentrifugal analysis of serum lipoproteins. Methods of biochemical analysis. ,vol. 1, pp. 459- 478 ,(1954) , 10.1002/9780470110171.CH16
Rachel H. Mackey, Philip Greenland, David C. Goff, Donald Lloyd-Jones, Christopher T. Sibley, Samia Mora, High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). Journal of the American College of Cardiology. ,vol. 60, pp. 508- 516 ,(2012) , 10.1016/J.JACC.2012.03.060
N.E. Miller, D.S. Thelle, O.H. Førde, O.D. Mjøs, The Tromso Heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. The Lancet. ,vol. 309, pp. 965- 968 ,(1977) , 10.1016/S0140-6736(77)92274-7
Rakesh S. Birjmohun, Barbara A. Hutten, John J.P. Kastelein, Erik S.G. Stroes, Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. Journal of the American College of Cardiology. ,vol. 45, pp. 185- 197 ,(2005) , 10.1016/J.JACC.2004.10.031
Tamio Teramoto, Hitoshi Shimano, Koutaro Yokote, Mitsuyoshi Urashima, Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. ,vol. 16, pp. 654- 661 ,(2009) , 10.5551/JAT.1719
, Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients New England Journal of Medicine. ,vol. 371, pp. 203- 212 ,(2014) , 10.1056/NEJMOA1300955